| Dr Sumana Koduri, MD | |
|
18200 W Capitol Dr Ste 200, Brookfield, WI 53045-1446 | |
| (262) 444-5148 | |
| (262) 444-5457 |
| Full Name | Dr Sumana Koduri |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 30 Years |
| Location | 18200 W Capitol Dr Ste 200, Brookfield, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942252762 | NPI | - | NPPES |
| 1942252762 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2088F0040X | Urology - Female Pelvic Medicine And Reconstructive Surgery | 36975 (Wisconsin) | Primary |
| 207V00000X | Obstetrics & Gynecology | 36975 (Wisconsin) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Froedtert Memorial Lutheran Hospital | Milwaukee, WI | Hospital |
| Ascension Se Wisconsin Hospital - St Joseph Campus | Milwaukee, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Froedtert Andthe Medical College Of Wisconsin Community Physicians Inc | 3678760063 | 1040 |
| Saak, Sc | 0244686137 | 2 |
| The Medical College Of Wisconsin Inc | 2668384371 | 1813 |
News Archive
A new study says California hospitals in areas with large minority populations are disproportionately affected by overcrowding at ERs - often leading to ambulance diversion, delayed care and poorer health outcomes for patients.
SpectraScience, Inc. has announced that it has received the official decision for the grant of another European Patent number 1063921 for its "Optical Biopsy Forceps System and Method of Sampling Tissue."
Bristol-Myers Squibb Company and Pfizer today announced that the companies have agreed to stop the Phase 3 AVERROES clinical trial of apixaban in patients with atrial fibrillation. The study will be stopped early because a predefined interim analysis by the independent Data Monitoring Committee (DMC) revealed clear evidence of a clinically important reduction in stroke and systemic embolism in patients with atrial fibrillation considered intolerant of or unsuitable for vitamin K antagonist therapy who received apixaban as compared to aspirin.
Students preparing for final exams might want to wait before pulling an all-night cram session - at least as far as their neurons are concerned. Carnegie Mellon University neuroscientists have discovered a new intermediate phase in neuronal development during which repeated exposure to a stimulus shrinks synapses.
Nearly 100 years after a British neurologist first mapped the blind spots caused by missile wounds to the brains of soldiers, Perelman School of Medicine researchers at the University of Pennsylvania have perfected his map using modern-day technology. Their results create a map of vision in the brain based upon an individual's brain structure, even for people who cannot see.
› Verified 6 days ago
| Entity Name | The Medical College Of Wisconsin Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699720086 PECOS PAC ID: 2668384371 Enrollment ID: O20031120000259 |
News Archive
A new study says California hospitals in areas with large minority populations are disproportionately affected by overcrowding at ERs - often leading to ambulance diversion, delayed care and poorer health outcomes for patients.
SpectraScience, Inc. has announced that it has received the official decision for the grant of another European Patent number 1063921 for its "Optical Biopsy Forceps System and Method of Sampling Tissue."
Bristol-Myers Squibb Company and Pfizer today announced that the companies have agreed to stop the Phase 3 AVERROES clinical trial of apixaban in patients with atrial fibrillation. The study will be stopped early because a predefined interim analysis by the independent Data Monitoring Committee (DMC) revealed clear evidence of a clinically important reduction in stroke and systemic embolism in patients with atrial fibrillation considered intolerant of or unsuitable for vitamin K antagonist therapy who received apixaban as compared to aspirin.
Students preparing for final exams might want to wait before pulling an all-night cram session - at least as far as their neurons are concerned. Carnegie Mellon University neuroscientists have discovered a new intermediate phase in neuronal development during which repeated exposure to a stimulus shrinks synapses.
Nearly 100 years after a British neurologist first mapped the blind spots caused by missile wounds to the brains of soldiers, Perelman School of Medicine researchers at the University of Pennsylvania have perfected his map using modern-day technology. Their results create a map of vision in the brain based upon an individual's brain structure, even for people who cannot see.
› Verified 6 days ago
| Entity Name | Froedtert &the Medical College Of Wisconsin Community Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568787448 PECOS PAC ID: 3678760063 Enrollment ID: O20101210000699 |
News Archive
A new study says California hospitals in areas with large minority populations are disproportionately affected by overcrowding at ERs - often leading to ambulance diversion, delayed care and poorer health outcomes for patients.
SpectraScience, Inc. has announced that it has received the official decision for the grant of another European Patent number 1063921 for its "Optical Biopsy Forceps System and Method of Sampling Tissue."
Bristol-Myers Squibb Company and Pfizer today announced that the companies have agreed to stop the Phase 3 AVERROES clinical trial of apixaban in patients with atrial fibrillation. The study will be stopped early because a predefined interim analysis by the independent Data Monitoring Committee (DMC) revealed clear evidence of a clinically important reduction in stroke and systemic embolism in patients with atrial fibrillation considered intolerant of or unsuitable for vitamin K antagonist therapy who received apixaban as compared to aspirin.
Students preparing for final exams might want to wait before pulling an all-night cram session - at least as far as their neurons are concerned. Carnegie Mellon University neuroscientists have discovered a new intermediate phase in neuronal development during which repeated exposure to a stimulus shrinks synapses.
Nearly 100 years after a British neurologist first mapped the blind spots caused by missile wounds to the brains of soldiers, Perelman School of Medicine researchers at the University of Pennsylvania have perfected his map using modern-day technology. Their results create a map of vision in the brain based upon an individual's brain structure, even for people who cannot see.
› Verified 6 days ago
| Entity Name | Saak, Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518744986 PECOS PAC ID: 0244686137 Enrollment ID: O20231030001049 |
News Archive
A new study says California hospitals in areas with large minority populations are disproportionately affected by overcrowding at ERs - often leading to ambulance diversion, delayed care and poorer health outcomes for patients.
SpectraScience, Inc. has announced that it has received the official decision for the grant of another European Patent number 1063921 for its "Optical Biopsy Forceps System and Method of Sampling Tissue."
Bristol-Myers Squibb Company and Pfizer today announced that the companies have agreed to stop the Phase 3 AVERROES clinical trial of apixaban in patients with atrial fibrillation. The study will be stopped early because a predefined interim analysis by the independent Data Monitoring Committee (DMC) revealed clear evidence of a clinically important reduction in stroke and systemic embolism in patients with atrial fibrillation considered intolerant of or unsuitable for vitamin K antagonist therapy who received apixaban as compared to aspirin.
Students preparing for final exams might want to wait before pulling an all-night cram session - at least as far as their neurons are concerned. Carnegie Mellon University neuroscientists have discovered a new intermediate phase in neuronal development during which repeated exposure to a stimulus shrinks synapses.
Nearly 100 years after a British neurologist first mapped the blind spots caused by missile wounds to the brains of soldiers, Perelman School of Medicine researchers at the University of Pennsylvania have perfected his map using modern-day technology. Their results create a map of vision in the brain based upon an individual's brain structure, even for people who cannot see.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sumana Koduri, MD 18200 W Capitol Dr Ste 200, Brookfield, WI 53045-1446 Ph: (262) 444-5148 | Dr Sumana Koduri, MD 18200 W Capitol Dr Ste 200, Brookfield, WI 53045-1446 Ph: (262) 444-5148 |
News Archive
A new study says California hospitals in areas with large minority populations are disproportionately affected by overcrowding at ERs - often leading to ambulance diversion, delayed care and poorer health outcomes for patients.
SpectraScience, Inc. has announced that it has received the official decision for the grant of another European Patent number 1063921 for its "Optical Biopsy Forceps System and Method of Sampling Tissue."
Bristol-Myers Squibb Company and Pfizer today announced that the companies have agreed to stop the Phase 3 AVERROES clinical trial of apixaban in patients with atrial fibrillation. The study will be stopped early because a predefined interim analysis by the independent Data Monitoring Committee (DMC) revealed clear evidence of a clinically important reduction in stroke and systemic embolism in patients with atrial fibrillation considered intolerant of or unsuitable for vitamin K antagonist therapy who received apixaban as compared to aspirin.
Students preparing for final exams might want to wait before pulling an all-night cram session - at least as far as their neurons are concerned. Carnegie Mellon University neuroscientists have discovered a new intermediate phase in neuronal development during which repeated exposure to a stimulus shrinks synapses.
Nearly 100 years after a British neurologist first mapped the blind spots caused by missile wounds to the brains of soldiers, Perelman School of Medicine researchers at the University of Pennsylvania have perfected his map using modern-day technology. Their results create a map of vision in the brain based upon an individual's brain structure, even for people who cannot see.
› Verified 6 days ago